Regeneron Pharmaceuticals Stock Shares Outstanding

REGN Stock  USD 966.30  2.75  0.29%   
Regeneron Pharmaceuticals fundamentals help investors to digest information that contributes to Regeneron Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Regeneron Stock. The fundamental analysis module provides a way to measure Regeneron Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Regeneron Pharmaceuticals stock.
As of the 28th of March 2024, Common Stock Shares Outstanding is likely to drop to about 75.4 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Regeneron Shares Outstanding Analysis

Regeneron Pharmaceuticals' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
 2021 2022 2023 2024 (projected)
Total Operating Expenses4.7B5.6B7.1B7.4B
Cost Of Revenue2.4B1.6B883.7M927.9M

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Regeneron Pharmaceuticals Shares Outstanding

    
  107.94 M  
Most of Regeneron Pharmaceuticals' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Regeneron Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Regeneron Shares Outstanding Driver Correlations

Understanding the fundamental principles of building solid financial models for Regeneron Pharmaceuticals is extremely important. It helps to project a fair market value of Regeneron Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Regeneron Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Regeneron Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Regeneron Pharmaceuticals' interrelated accounts and indicators.
1.0-0.060.990.980.32-0.660.970.980.830.940.980.580.930.580.430.870.290.950.761.00.960.990.650.88-0.910.760.610.9-0.67
1.0-0.090.990.960.28-0.670.950.970.850.960.960.550.940.560.380.850.270.940.741.00.940.990.640.87-0.90.770.620.9-0.69
-0.06-0.090.0-0.01-0.04-0.490.02-0.090.03-0.16-0.08-0.040.01-0.40.24-0.26-0.12-0.15-0.26-0.090.160.03-0.26-0.13-0.190.10.16-0.04-0.15
0.990.990.00.960.27-0.750.950.970.870.960.950.530.950.480.360.820.190.90.690.990.960.990.590.86-0.930.780.630.91-0.7
0.980.96-0.010.960.33-0.650.990.990.710.890.980.620.850.560.490.870.320.950.760.970.970.960.660.92-0.950.660.50.91-0.56
0.320.28-0.040.270.33-0.130.420.390.120.140.450.690.120.240.60.530.180.360.720.280.40.30.150.42-0.4-0.010.020.310.14
-0.66-0.67-0.49-0.75-0.65-0.13-0.63-0.65-0.71-0.66-0.61-0.25-0.710.11-0.19-0.390.26-0.46-0.24-0.67-0.75-0.73-0.15-0.590.81-0.58-0.48-0.730.57
0.970.950.020.950.990.42-0.630.970.710.860.990.680.840.610.590.890.340.960.820.960.980.960.690.88-0.940.670.540.87-0.57
0.980.97-0.090.970.990.39-0.650.970.750.910.980.610.850.530.440.890.270.930.790.980.960.960.630.94-0.940.630.460.94-0.53
0.830.850.030.870.710.12-0.710.710.750.870.720.280.940.370.130.540.130.70.440.840.750.870.40.59-0.710.810.690.72-0.79
0.940.96-0.160.960.890.14-0.660.860.910.870.870.360.940.470.160.760.190.840.620.960.850.930.540.82-0.820.770.580.89-0.7
0.980.96-0.080.950.980.45-0.610.990.980.720.870.730.840.590.540.910.290.960.840.970.960.960.670.9-0.920.660.540.88-0.55
0.580.55-0.040.530.620.69-0.250.680.610.280.360.730.410.490.720.680.240.670.740.560.620.560.510.56-0.570.320.390.43-0.23
0.930.940.010.950.850.12-0.710.840.850.940.940.840.410.470.240.70.180.830.570.940.860.950.520.69-0.790.90.790.79-0.85
0.580.56-0.40.480.560.240.110.610.530.370.470.590.490.470.50.630.60.770.70.560.470.530.90.4-0.340.450.390.32-0.33
0.430.380.240.360.490.6-0.190.590.440.130.160.540.720.240.50.620.280.580.660.380.560.430.540.34-0.490.220.330.24-0.12
0.870.85-0.260.820.870.53-0.390.890.890.540.760.910.680.70.630.620.280.90.920.860.850.820.640.81-0.770.530.470.75-0.41
0.290.27-0.120.190.320.180.260.340.270.130.190.290.240.180.60.280.280.420.350.260.230.250.320.25-0.170.250.120.18-0.04
0.950.94-0.150.90.950.36-0.460.960.930.70.840.960.670.830.770.580.90.420.850.940.90.920.810.81-0.830.690.570.78-0.57
0.760.74-0.260.690.760.72-0.240.820.790.440.620.840.740.570.70.660.920.350.850.750.750.710.660.72-0.670.420.370.62-0.29
1.01.0-0.090.990.970.28-0.670.960.980.840.960.970.560.940.560.380.860.260.940.750.950.990.640.87-0.90.770.620.9-0.68
0.960.940.160.960.970.4-0.750.980.960.750.850.960.620.860.470.560.850.230.90.750.950.970.590.86-0.970.70.580.88-0.61
0.990.990.030.990.960.3-0.730.960.960.870.930.960.560.950.530.430.820.250.920.710.990.970.620.84-0.930.780.650.89-0.71
0.650.64-0.260.590.660.15-0.150.690.630.40.540.670.510.520.90.540.640.320.810.660.640.590.620.52-0.50.470.370.46-0.34
0.880.87-0.130.860.920.42-0.590.880.940.590.820.90.560.690.40.340.810.250.810.720.870.860.840.52-0.910.480.210.97-0.26
-0.91-0.9-0.19-0.93-0.95-0.40.81-0.94-0.94-0.71-0.82-0.92-0.57-0.79-0.34-0.49-0.77-0.17-0.83-0.67-0.9-0.97-0.93-0.5-0.91-0.58-0.41-0.930.48
0.760.770.10.780.66-0.01-0.580.670.630.810.770.660.320.90.450.220.530.250.690.420.770.70.780.470.48-0.580.890.58-0.81
0.610.620.160.630.50.02-0.480.540.460.690.580.540.390.790.390.330.470.120.570.370.620.580.650.370.21-0.410.890.31-0.9
0.90.9-0.040.910.910.31-0.730.870.940.720.890.880.430.790.320.240.750.180.780.620.90.880.890.460.97-0.930.580.31-0.4
-0.67-0.69-0.15-0.7-0.560.140.57-0.57-0.53-0.79-0.7-0.55-0.23-0.85-0.33-0.12-0.41-0.04-0.57-0.29-0.68-0.61-0.71-0.34-0.260.48-0.81-0.9-0.4
Click cells to compare fundamentals
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Regeneron Common Stock Shares Outstanding

Common Stock Shares Outstanding

75.36 Million

At this time, Regeneron Pharmaceuticals' Common Stock Shares Outstanding is very stable compared to the past year.
Based on the latest financial disclosure, Regeneron Pharmaceuticals has 107.94 M of shares currently outstending. This is 40.21% lower than that of the Biotechnology sector and about the same as Health Care (which currently averages 106.85 M) industry. The shares outstanding for all United States stocks is 81.12% higher than that of the company.

Regeneron Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Regeneron Pharmaceuticals' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Regeneron Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Regeneron Pharmaceuticals by comparing valuation metrics of similar companies.
Regeneron Pharmaceuticals is currently under evaluation in shares outstanding category among related companies.

Regeneron Pharmaceuticals ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Regeneron Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Regeneron Pharmaceuticals' managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Regeneron Fundamentals

About Regeneron Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Regeneron Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Regeneron Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Regeneron Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Common Stock Shares Outstanding113.7 M75.4 M

Currently Active Assets on Macroaxis

When determining whether Regeneron Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regeneron Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regeneron Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regeneron Pharmaceuticals Stock:
Check out Regeneron Pharmaceuticals Piotroski F Score and Regeneron Pharmaceuticals Altman Z Score analysis.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.
Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Regeneron Stock analysis

When running Regeneron Pharmaceuticals' price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.03)
Earnings Share
34.78
Revenue Per Share
122.935
Quarterly Revenue Growth
0.006
Return On Assets
0.0849
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.